S-HYDROXOCOBALAMIN 1000MCG/ML MDV INJ; packaged in a) 10ML b) 30ML glass vial, Red Mountain Compounding Rx
Published November 13, 2019 · Recall initiated: August 12, 2019
Summary
FDA records drug Class II recall D-0268-2020, published November 13, 2019 and initiated August 12, 2019. Recalling firm: First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy; Status: Terminated; Reported quantity: N/A; Lot: Lot #:a) S07162019DT@04, Exp 10/16/19; b) S07162019DT@04 Exp 10/16/19. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Lack of Assurance of Sterility
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy
- Distributor
- Nationwide in the USA
- Lot
- Lot #:a) S07162019DT@04, Exp 10/16/19; b) S07162019DT@04 Exp 10/16/19
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAMETHYLCOBALAMIN 10,000MCG/ML MDV INJ, Rx only, Red Mountain Compounding RxNovember 3, 2021
- FDATEST CYP 50MG/ML IN ETHYL OLEATE OIL, Rx only, Red Mountain Compounding RxNovember 3, 2021
- FDADEXPANTHENOL 250MG/ML INJ SOLN, Rx only, Red Mountain Compounding RxNovember 3, 2021
- FDAPYRIDOXINE HCL (B6) 100MG/ML MDV, Red Mountain Compounding RxNovember 3, 2021
- FDAS-HCG/B12A 1000U/5MG/ML MDV INJ, packaged in a) 5ML b) 10 ML glass vials, Rx Only, Red Mountain CompoundingNovember 13, 2019
- FDAS-LIDOCAINE HCL 2% MDV INJ SOLN, packaged in 50ML vial, Red Mountain Compounding Rx,November 13, 2019
Questions about this recall
Was S-HYDROXOCOBALAMIN 1000MCG/ML MDV INJ; packaged in a) 10ML b) 30ML glass vial, Red Mountain Compounding Rx recalled?
Yes. FDA published recall D-0268-2020 on November 13, 2019. Reported hazard: Lack of Assurance of Sterility
What should I do if I have this product?
Voluntary: Firm initiated · Letter